127 related articles for article (PubMed ID: 36610112)
1. Efficacy and mechanism study of cordycepin against brain metastases of small cell lung cancer based on zebrafish.
Zhang SR; Pan M; Gao YB; Fan RY; Bin XN; Qian ST; Tang CL; Ying HJ; Wu JQ; He MF
Phytomedicine; 2023 Jan; 109():154613. PubMed ID: 36610112
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical characteristics of brain metastases and corresponding primary lung cancer.
Marinova Marinova D; Vitkov Mekov E; Gosheva Dimitrova D; Todorov Titorenkov P; Martinov Mihailov M; Slavov Nachev S; Milosheva Youroukova V; Temelkov Kostadinov D; Georgieva Slavova Y
J BUON; 2019; 24(4):1626-1637. PubMed ID: 31646818
[TBL] [Abstract][Full Text] [Related]
3. PROTAC EZH2 degrader-1 overcomes the resistance of podophyllotoxin derivatives in refractory small cell lung cancer with leptomeningeal metastasis.
Shi MX; Ding X; Tang L; Cao WJ; Su B; Zhang J
BMC Cancer; 2024 Apr; 24(1):504. PubMed ID: 38644473
[TBL] [Abstract][Full Text] [Related]
4. Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC).
Berghoff AS; Ricken G; Wilhelm D; Rajky O; Widhalm G; Dieckmann K; Birner P; Bartsch R; Preusser M
J Neurooncol; 2016 Oct; 130(1):19-29. PubMed ID: 27436101
[TBL] [Abstract][Full Text] [Related]
5. Elevated PLGF contributes to small-cell lung cancer brain metastasis.
Li B; Wang C; Zhang Y; Zhao XY; Huang B; Wu PF; Li Q; Li H; Liu YS; Cao LY; Dai WM; Fang WG; Shang DS; Cao L; Zhao WD; Chen YH
Oncogene; 2013 Jun; 32(24):2952-62. PubMed ID: 22797069
[TBL] [Abstract][Full Text] [Related]
6. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.
Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q
Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408
[TBL] [Abstract][Full Text] [Related]
7. Zebrafish xenograft model for studying mechanism and treatment of non-small cell lung cancer brain metastasis.
Fan RY; Wu JQ; Liu YY; Liu XY; Qian ST; Li CY; Wei P; Song Z; He MF
J Exp Clin Cancer Res; 2021 Nov; 40(1):371. PubMed ID: 34801071
[TBL] [Abstract][Full Text] [Related]
8. Etk Interaction with PFKFB4 Modulates Chemoresistance of Small-cell Lung Cancer by Regulating Autophagy.
Wang Q; Zeng F; Sun Y; Qiu Q; Zhang J; Huang W; Huang J; Huang X; Guo L
Clin Cancer Res; 2018 Feb; 24(4):950-962. PubMed ID: 29208667
[No Abstract] [Full Text] [Related]
9. RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding.
Lin Y; Wu Y; Zhang Q; Tu X; Chen S; Pan J; Xu N; Lin M; She P; Niu G; Chen Y; Li H
J Exp Clin Cancer Res; 2024 Jan; 43(1):1. PubMed ID: 38163890
[TBL] [Abstract][Full Text] [Related]
10. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
[TBL] [Abstract][Full Text] [Related]
11. New metastatic model of human small-cell lung cancer by orthotopic transplantation in mice.
Sakamoto S; Inoue H; Ohba S; Kohda Y; Usami I; Masuda T; Kawada M; Nomoto A
Cancer Sci; 2015 Apr; 106(4):367-74. PubMed ID: 25640943
[TBL] [Abstract][Full Text] [Related]
12. Tumor markers for lipid metabolism-related genes: Based on small cell lung cancer and bronchial asthma dual analysis.
Wang X; Gao Y; Wang H; Gong X; Bao P
Environ Toxicol; 2024 May; 39(5):2855-2868. PubMed ID: 38293814
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells.
Wang ZX; Lu BB; Yang JS; Wang KM; De W
J Surg Res; 2011 Nov; 171(1):127-35. PubMed ID: 20338593
[TBL] [Abstract][Full Text] [Related]
15. Anlotinib plus etoposide and cisplatin/carboplatin as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC): a single-arm, phase II study.
Kong T; Chen L; Zhao X; Duan F; Zhou H; Wang L; Liu D
Invest New Drugs; 2022 Oct; 40(5):1095-1105. PubMed ID: 35788937
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression and clinical outcome of small cell lung cancer.
Lee JH; Voortman J; Dingemans AM; Voeller DM; Pham T; Wang Y; Giaccone G
PLoS One; 2011; 6(6):e21300. PubMed ID: 21731696
[TBL] [Abstract][Full Text] [Related]
17. Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer.
Owonikoko TK; Zhang G; Deng X; Rossi MR; Switchenko JM; Doho GH; Chen Z; Kim S; Strychor S; Christner SM; Beumer J; Li C; Yue P; Chen A; Sica GL; Ramalingam SS; Kowalski J; Khuri FR; Sun SY
Cancer Med; 2014 Dec; 3(6):1579-94. PubMed ID: 25124282
[TBL] [Abstract][Full Text] [Related]
18. Specific expression of OATPs in primary small cell lung cancer (SCLC) cells as novel biomarkers for diagnosis and therapy.
Brenner S; Klameth L; Riha J; Schölm M; Hamilton G; Bajna E; Ausch C; Reiner A; Jäger W; Thalhammer T; Buxhofer-Ausch V
Cancer Lett; 2015 Jan; 356(2 Pt B):517-24. PubMed ID: 25301452
[TBL] [Abstract][Full Text] [Related]
19. Expression profiling of angiogenesis-related genes in brain metastases of lung cancer and melanoma.
Ilhan-Mutlu A; Siehs C; Berghoff AS; Ricken G; Widhalm G; Wagner L; Preusser M
Tumour Biol; 2016 Jan; 37(1):1173-82. PubMed ID: 26277786
[TBL] [Abstract][Full Text] [Related]
20. Brain metastases from small cell lung cancer and non-small cell lung cancer: comparison of spatial distribution and identification of metastatic risk regions.
Shi W; Wang Y; Xia W; Liu B; Ni M; Shen J; Bai Y; Weng G; Liu W; Yuan S; Gao X
J Neurooncol; 2023 Jan; 161(1):97-105. PubMed ID: 36520380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]